肠道菌群在急性髓系白血病中的研究进展
Advances in the Study of Intestinal Flora in Acute Myeloid Leukemia
DOI: 10.12677/ACM.2023.1361284, PDF,   
作者: 包雪伟：青海大学研究生院，青海 西宁；李文倩*：青海省人民医院血液科，青海 西宁
关键词: 肠道菌群；急性髓系白血病；治疗；益生菌；Intestinal Flora； Acute Myeloid Leukemia； Treatment； Probiotics
摘要: 急性髓系白血病是一种起源于造血干细胞/祖细胞的恶性克隆性疾病，是成人白血病中最常见的类型。肠道菌群是人体微生物最大、最复杂群落，与人体的正常的生命活动、内环境的稳定及免疫系统密切相关。研究发现，肠道菌群与AML之间存在相互作用。近年来研究发现，肠道菌群通过多种机制影响AML的发生，并与其治疗、预后及预防均有着密切的关系。本文就肠道菌群对AML的发生、治效及预后的影响及相关机制进行综述，旨在为AML的治疗和预防提供新思路。
Abstract: Acute myeloid leukemia is a malignant clonal disease that originates from hematopoietic stem/pro genitor cells and is the most common type of adult leukemia. The intestinal flora is the largest and most complex community of microorganisms in the human body, and is closely related to the nor-mal life activities, stability of the internal environment and immune system. It has been found that there is an interaction between intestinal flora and AML. Recent studies have found that intestinal flora affects the occurrence of AML through various mechanisms, and has a close relationship with its treatment, prognosis and prevention. In this paper, we review the effects of intestinal flora on the occurrence, treatment and prognosis of AML and the related mechanisms, aiming to provide new ideas for the treatment and prevention of AML.
文章引用：包雪伟, 李文倩. 肠道菌群在急性髓系白血病中的研究进展[J]. 临床医学进展, 2023, 13(6): 9170-9176. https://doi.org/10.12677/ACM.2023.1361284

参考文献

[1] Zhai, H., Zhao, J., Pu, J., et al. (2021) LncRNA-DUXAP8 Regulation of the Wnt/beta-Catenin Signaling Pathway to In-hibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia. Turkish Journal of Haematology, 38, 264-272. [Google Scholar] [CrossRef] 
[2] Allison, M., Mathews, J., Gilliland, T., et al. (2022) Nat-ural Killer Cell-Mediated Immunotherapy for Leukemia. Cancers (Basel), 14, Article No. 843. [Google Scholar] [CrossRef] 
[3] Sarin, S.-K., Pande, A. and Schnabl, B. (2019) Microbiome as a Therapeutic Target in Alcohol-Related Liver Disease. Journal of Hepatology, 70, 260-272. [Google Scholar] [CrossRef] 
[4] Landman, C. and Quevrain, E. (2016) Gut Microbiota: Description, Role and Pathophysiologic Implications. La Revue de Médecine Interne, 37, 418-423. [Google Scholar] [CrossRef] 
[5] Grandt, C.-L., Brackmann, L.-K., Poplawski, A., et al. (2022) Radiation-Response in Primary Fibroblasts of Long-Term Survivors of Childhood Cancer with and without Second Pri-mary Neoplasms: The KiKme Study. Molecular Medicine, 28, Article No. 105. [Google Scholar] [CrossRef] 
[6] Rothschild, D., Weissbrod, O., Barkan, E., et al. (2018) Envi-ronment Dominates over Host Genetics in Shaping Human Gut Microbiota. Nature, 555, 210-215. [Google Scholar] [CrossRef] 
[7] DeFilipp, Z., Hohmann, E., Jenq, R.-R., et al. (2019) Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 25, e17-e22. [Google Scholar] [CrossRef] 
[8] Vivarelli, S., Salemi, R., Candido, S., et al. (2019) Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel), 11, Article No. 38. [Google Scholar] [CrossRef] 
[9] Marcotte, E.-L., Richardson, M.-R., Roesler, M.-A., et al. (2018) Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children’s Oncology Group. Cancer Epide-miology, Biomarkers & Prevention, 27, 473-478. [Google Scholar] [CrossRef] 
[10] Zhou, Y.-J., Zhao, D.-D., Liu, H., et al. (2017) Cancer Killers in the Human Gut Microbiota: Diverse Phylogeny and Broad Spectra. Oncotarget, 8, 49574-49591. [Google Scholar] [CrossRef] 
[11] Ostgard, L.S.G., Norgaard, M., Pedersen, L., et al. (2018) Auto-immune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukaemia: A National Popula-tion-Based Case-Control Study. British Journal of Haematology, 181, 205-214. [Google Scholar] [CrossRef] 
[12] Chiba, S. (2016) Significance of TET2 Mutations in Myeloid and Lymphoid Neoplasms. Rinsho Ketsueki, 57, 715-722.
[13] Meisel, M., Reinhard, H., Alain, P., et al. (2018) Microbial Signals Drive Pre-Leukaemic Myeloproliferation in a Tet2-Deficient Host. Nature (London), 557, 580-584. [Google Scholar] [CrossRef] 
[14] Zhang, Y., Yu, X., Lin, D., et al. (2017) Propiece IL-1alpha Facil-itates the Growth of Acute T-Lymphocytic Leukemia Cells through the Activation of NF-kappaB and SP1. Oncotarget, 8, 15677-15688. [Google Scholar] [CrossRef] 
[15] Mauray, A., Felgines, C., Morand, C., et al. (2010) Bilberry An-thocyanin-Rich Extract Alters Expression of Genes Related to Atherosclerosis Development in Aorta of apo E-Deficient Mice. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 22, 72-80.
[16] Willemsen, M.L.-E. (2003) Short Chain Fatty Acids Stimulate Epithelial Mucin 2 Expression through Differential Effects on Prostaglandin E1 and E2 Production by Intestinal Myofibroblasts. Gut, 52, 1442-1447. [Google Scholar] [CrossRef] 
[17] Illiano, P., Brambilla, R. and Parolini, C. (2020) The Mutual Interplay of Gut Microbiota, Diet and Human Disease. FEBS Journal, 287, 833-855. [Google Scholar] [CrossRef] 
[18] Bai, L., Zhou, P., Li, D., et al. (2017) Changes in the Gastrointestinal Mi-crobiota of Children with Acute Lymphoblastic Leukaemia and Its Association with Antibiotics in the Short Term. Jour-nal of Medical Microbiology, 66, 1297-1307. [Google Scholar] [CrossRef] 
[19] Galloway-Pena, J.-R., Smith, D.-P., Sahasrabhojane, P., et al. (2016) The Role of the Gastrointestinal Microbiome in Infectious Complications during Induction Chemotherapy for Acute My-eloid Leukemia. Cancer, 122, 2186-2196. [Google Scholar] [CrossRef] 
[20] Galloway-Pena, J.-R., Smith, D.-P., Sahasrabhojane, P., et al. (2017) Characterization of Oral and Gut Microbiome Temporal Variability in Hospitalized Cancer Patients. Genome Medicine, 9, Article No. 21. [Google Scholar] [CrossRef] 
[21] Ziegler, M., Han, J.-H., Landsburg, D., et al. (2019) Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malig-nancy. Open Forum Infectious Diseases, 6, z252. [Google Scholar] [CrossRef] 
[22] Lee, S., Ritchie, E.-K., Miah, S., et al. (2019) Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy. Blood, 134, Article No. 1336. [Google Scholar] [CrossRef] 
[23] Gyarmati, P., Kjellander, C., Aust, C., et al. (2016) Metagenomic Analysis of Bloodstream Infections in Patients with Acute Leukemia and Therapy-Induced Neutropenia. Scientific Re-ports, 6, Article No. 23532. [Google Scholar] [CrossRef] 
[24] Rashidi, A., Kaiser, T., Shields-Cutler, R., et al. (2019) Dysbiosis Patterns during Re-Induction/Salvage versus Induction Chemotherapy for Acute Leukemia. Scientific Reports, 9, Article No. 6083. [Google Scholar] [CrossRef] 
[25] van Vliet, M.-J., Tissing, W.-J., Dun, C.-A., et al. (2009) Chem-otherapy Treatment in Pediatric Patients with Acute myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut. Clinical Infectious Diseases, 49, 262-270. [Google Scholar] [CrossRef] 
[26] Kato, S., Hamouda, N., Kano, Y., et al. (2017) Probiotic Bifidobac-terium Bifidum G9-1 Attenuates 5-Fluorouracil-Induced Intestinal Mucositis in Mice via Suppression of Dysbio-sis-Related Secondary Inflammatory Responses. Clinical and Experimental Pharmacology and Physiology, 44, 1017-1025. [Google Scholar] [CrossRef] 
[27] Eriguchi, Y., Takashima, S., Oka, H., et al. (2012) Graft-versus-Host Disease Disrupts Intestinal Microbial Ecology by Inhibiting Paneth Cell Production of Al-pha-Defensins. Blood, 120, 223-231. [Google Scholar] [CrossRef] 
[28] Jenq, R.-R., Taur, Y., Devlin, S.-M., et al. (2015) Intestinal Blautia Is Associated with Reduced Death from Graft- versus-Host Disease. Biology of Blood and Marrow Transplanta-tion, 21, 1373-1383. [Google Scholar] [CrossRef] 
[29] Mathewson, N.-D., Jenq, R., Mathew, A.-V., et al. (2016) Gut Microbiome-Derived Metabolites Modulate Intestinal Epithelial Cell Damage and Mitigate Graft-versus-Host Disease. Nature Immunology, 17, 505-513. [Google Scholar] [CrossRef] 
[30] Mohty, M., Malard, F., D’Incan, E., et al. (2017) Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Pa-tients Undergoing Intensive Treatment (ODYSSEE Study): First Results of a Prospective Multicenter Trial. Blood, 130, Article No. 2624. [Google Scholar] [CrossRef] 
[31] Mohty, M., Malard, F., Vekhoff, A., et al. (2018) The Odys-see Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial. Blood: The Jour-nal of the American Society of Hematology, 132, Article No. 1444. [Google Scholar] [CrossRef] 
[32] DeFilipp, Z., Peled, J.-U., Li, S., et al. (2018) Third-Party Fe-cal Microbiota Transplantation Following allo-HCT Reconstitutes Microbiome Diversity. Blood Advances, 2, 745-753. [Google Scholar] [CrossRef] 
[33] Bilinski, J., Grzesiowski, P., Sorensen, N., et al. (2017) Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study. Clinical Infectious Diseases, 65, 364-370. [Google Scholar] [CrossRef] 
[34] Kaito, S., Toya, T., Yoshifuji, K., et al. (2018) Fecal Microbiota Transplan-tation with Frozen Capsules for a Patient with Refractory Acute Gut Graft-versus-Host Disease. Blood Advances, 2, 3097-3101. [Google Scholar] [CrossRef] 
[35] Koontz, J.-M., Dancy, B.C.R., Horton, C.-L., et al. (2019) The Role of the Human Microbiome in Chemical Toxicity. International Journal of Toxicology, 38, 251-264. [Google Scholar] [CrossRef] 
[36] Ma, W., Mao, Q., Xia, W., et al. (2019) Gut Microbiota Shapes the Efficiency of Cancer Therapy. Frontiers in Microbiology, 10, Article No. 1050. [Google Scholar] [CrossRef] [PubMed]
[37] Alexander, J.-L., Wilson, I.-D., Teare, J., et al. (2017) Gut Micro-biota Modulation of Chemotherapy Efficacy and Toxicity. Nature Reviews Gastroenterology & Hepatology, 14, 356-365. [Google Scholar] [CrossRef] [PubMed]
[38] Huang, K., Liu, Y., Tang, H., et al. (2019) Glabridin Prevents Dox-orubicin-Induced Cardiotoxicity through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice. Frontiers in Pharmacology, 10, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
[39] Urushiyama, D., Suda, W., Ohnishi, E., et al. (2017) Microbiome Profile of the Amniotic Fluid as a Predictive Biomarker of Perinatal Outcome. Scientific Reports, 7, Article No. 12171. [Google Scholar] [CrossRef] [PubMed]
[40] Bajaj, J.-S., Thacker, L.-R., Fagan, A., et al. (2018) Gut Micro-bial RNA and DNA Analysis Predicts Hospitalizations in Cirrhosis. JCI Insight, 3, Article No. 98019. [Google Scholar] [CrossRef] [PubMed]
[41] Mego, M., Holec, V., Drgona, L., et al. (2013) Probiotic Bacteria in Cancer Patients Undergoing Chemotherapy and Radiation Therapy. Complementary Therapies in Medicine, 21, 712-723. [Google Scholar] [CrossRef] [PubMed]
[42] Reyna-Figueroa, J., Barron-Calvillo, E., Garcia-Parra, C., et al. (2019) Probiotic Supplementation Decreases Chemotherapy-Induced Gastrointestinal Side Effects in Patients with Acute Leukemia. Journal of Pediatric Hematology/Oncology, 41, 468-472. [Google Scholar] [CrossRef] 
[43] Gerbitz, A., Schultz, M., Wilke, A., et al. (2004) Probiotic Effects on Experimental Graft-versus-Host Disease: Let Them Eat Yogurt. Blood, 103, 4365-4367. [Google Scholar] [CrossRef] [PubMed]
[44] Redman, M.-G., Ward, E.-J. and Phillips, R.-S. (2014) The Effi-cacy and Safety of Probiotics in People with Cancer: A Systematic Review. Annals of Oncology, 25, 1919-1929. [Google Scholar] [CrossRef] [PubMed]
[45] Evrensel, A. and Ceylan, M.-E. (2016) Fecal Microbiota Transplanta-tion and Its Usage in Neuropsychiatric Disorders. Clinical Psychopharmacology and Neuroscience, 14, 231-237. [Google Scholar] [CrossRef] [PubMed]
[46] Scher, J.-U., Ubeda, C., Artacho, A., et al. (2015) Decreased Bac-terial Diversity Characterizes the Altered Gut Microbiota in Patients with Psoriatic Arthritis, Resembling Dysbiosis in In-flammatory Bowel Disease. Arthritis & Rheumatology, 67, 128-139. [Google Scholar] [CrossRef] [PubMed]

为你推荐